Skip to content
10-Q

Quarterly Report

Sionna Therapeutics, Inc. SION

0001628280-26-033876

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 45.15M sh
Shares Diluted Q1 2026 · Mar 31, 2026 44.92M sh
Shares Diluted Q1 2026 · Mar 31, 2025 26.6M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $86K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$21.84M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$16.29M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $63.32M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $58.45M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $82.7M
Stockholders Equity Q1 2026 · Mar 31, 2026 $288.21M
Stockholders Equity Q1 2026 · Dec 31, 2025 $306.83M
Stockholders Equity Q1 2026 · Mar 31, 2025 $351.77M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$163.71M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.78M
Current Liabilities Q1 2026 · Dec 31, 2025 $11.71M
Total Liabilities Q1 2026 · Mar 31, 2026 $16.83M
Total Liabilities Q1 2026 · Dec 31, 2025 $19.12M
Current Assets Q1 2026 · Mar 31, 2026 $220.96M
Current Assets Q1 2026 · Dec 31, 2025 $241.42M
Total Assets Q1 2026 · Mar 31, 2026 $305.04M
Total Assets Q1 2026 · Dec 31, 2025 $325.95M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.60
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$0.62
Eps Basic Q1 2026 · Mar 31, 2026 −$0.60
Eps Basic restated Q1 2026 · Mar 31, 2025 −$0.62
Sga Expense Q1 2026 · Mar 31, 2026 $10.64M
Sga Expense Q1 2026 · Mar 31, 2025 $5.99M
Rd Expense Q1 2026 · Mar 31, 2026 $18.96M
Rd Expense Q1 2026 · Mar 31, 2025 $13.67M
Net Income Q1 2026 · Mar 31, 2026 −$26.78M
Net Income Q1 2026 · Mar 31, 2025 −$16.48M
Operating Income Q1 2026 · Mar 31, 2026 −$29.6M
Operating Income Q1 2026 · Mar 31, 2025 −$19.66M